Cancer Immunotherapy Triggered a Heart Attack in One Patient—Here’s What It Reveals
A new case report describes a 70-year-old lung cancer patient with no cardiovascular risk factors who suffered a massive heart ...
Tag: cardiotoxicity
Immune ‘Don’t Eat Me’ Protein CD47 Drives Chemotherapy-Induced Heart Aging in Male Mice
New research shows that the immune checkpoint protein CD47 rises in doxorubicin-damaged hearts and that blocking it with an antibody ...
Fibroblast Protein GNL3 Emerges as Hidden Culprit in Chemotherapy Heart Damage
New research in mice shows that the nucleolar protein GNL3, produced by cardiac fibroblasts, worsens doxorubicin-induced heart injury by driving ...
Stem Cell Screening Platform Hunts for Drugs to Halt Cardiac Fibrosis
Stanford researchers have published a protocol for a high-throughput stem cell-based screening platform that identifies potential antifibrotic compounds for cardiac ...
How Much Chemotherapy Is Too Much for a Child’s Heart? A New Study Urges Caution
A retrospective cohort study of 644 children with cancer finds that apparent links between anthracycline dose and heart injury depend ...
Lab-Grown Heart Models Move Closer to Predicting Human Cardiac Disease
A comprehensive review charts how cardiac organoids and engineered heart tissues are constructed, matured and translated toward predictive human cardiovascular ...
Cancer Immunotherapy’s Hidden Heart Risk: Landmark Review Maps Deadly Cardiac Side Effects
A systematic review of 116 case reports reveals that immune checkpoint inhibitors can trigger rare but often fatal heart complications, ...
Low-Dose Vitamin E Shields Heart and Kidneys from Arsenic Damage in Rats
A new rat study shows that low, sub-prooxidant doses of vitamin E protect both the heart and kidneys from acute ...
Income Protects Breast Cancer Survivors From Heart Disease Unequally, National Study Finds
A national analysis of nearly 2,800 female breast cancer survivors shows that higher income sharply reduces cardiovascular disease risk, but ...
Cancer Drug Lapatinib Offers Safer HER2 Route for Patients With Failing Hearts
A new clinical case report shows that the oral HER2 inhibitor lapatinib, with its short half-life and low cardiac toxicity, ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!